Patent · US Active

Diagnostic test for skeletal atavism in horses

US11286527B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignees

Capilet Genetics AB · SE
University of Washington · US

Inventors

Sofia Mikko · Knivsta, SE
Leif Andersson · Finspång, SE
Gabriella Lindgren · Knivsta, SE
Carl-Johan Rubin · Uppsala, SE
Bhanu Chowdhary · College Station, US
Terje Raudsepp · College Station, US
Evan E. Eichler · Seattle, US
John Huddleston · Seattle, US
Maika Malig · Seattle, US

Key dates

Filing date	Jun 11, 2018
Grant date	Mar 29, 2022
Priority date	—
Expiry date	Jun 11, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to methods for detecting a genetic deletion at the SHOX locus of a horse, where the presence of such a genetic deletion indicates that the horse is a carrier of disease-causing mutation that can lead to skeletal atavism. The invention further provides nucleic acid primers and probes for use in methods for detecting the presence or absence of disease-causing genetic deletion at the SHOX locus of a horse.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.